8th Annual Symposium: Contemporary Management of Cardiovascular Disease in Women 2025
Advanced Women’s Cardiology, Preventive Cardiovascular Medicine & Gender-Specific Heart Disease Update
The 8th Annual Symposium: Contemporary Management of Cardiovascular Disease in Women 2025 delivers a comprehensive review of the latest evidence-based strategies for diagnosing, preventing, and treating cardiovascular disease in women. This specialized cardiology program focuses on sex-specific differences in cardiovascular risk, clinical presentation, disease progression, and treatment outcomes, helping clinicians address persistent disparities in women’s cardiovascular healthcare.
Designed for cardiologists, internists, primary care physicians, advanced practice providers, and other healthcare professionals involved in cardiovascular care, the symposium explores emerging therapies, preventive strategies, advanced interventions, and modern guideline-based approaches to managing cardiovascular disease across the female lifespan.
Product Details
- Format: Video Lectures Only
- Course Year: 2025
- Access: On-Demand
- Level: Intermediate to Advanced
- Content Type: Women’s Cardiovascular Medicine Symposium
Program Overview
Cardiovascular disease remains the leading cause of death among women worldwide, yet significant differences in risk factors, disease presentation, diagnosis, and treatment continue to impact outcomes.
This symposium provides a focused review of:
- Women’s Cardiovascular Health
- Preventive Cardiology
- Coronary Artery Disease
- Heart Failure
- Arrhythmias
- Valvular Heart Disease
- Aortic Disease
- Hypertension
- Lipid Management
- Cardiovascular-Kidney-Metabolic (CKM) Syndrome
- Pregnancy-Associated Cardiac Disease
- Advanced Cardiovascular Therapies
Participants will gain practical strategies for recognizing unique cardiovascular conditions in women while applying contemporary therapies and evidence-based management approaches to improve patient outcomes.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Identify sex-specific cardiovascular risk factors and disease patterns in women.
- Apply contemporary ASCVD prevention and risk assessment strategies.
- Evaluate and manage coronary artery disease and acute coronary syndromes in female patients.
- Utilize advanced pharmacologic therapies for lipid disorders, hypertension, heart failure, and CKM syndrome.
- Assess cardiovascular complications related to pregnancy and hormonal changes.
- Implement evidence-based management strategies for atrial fibrillation, cardiac amyloidosis, and hypertrophic cardiomyopathy.
- Understand sex-related differences in valvular and aortic disease treatment outcomes.
- Integrate emerging interventional therapies into clinical cardiovascular practice.
Women’s Cardiovascular Risk & Prevention
A major focus of the symposium is improving cardiovascular risk assessment and prevention in women.
Topics include:
- Female-specific cardiovascular risk factors
- Menopause and cardiovascular health
- Pregnancy-related cardiovascular risk
- Hypertension in women
- Dyslipidemia management
- ASCVD risk assessment
- Cardiovascular prevention strategies
- Health disparities in women’s heart disease
Faculty review practical approaches to earlier detection and risk reduction.
Coronary Artery Disease in Women
The course examines important differences in coronary disease presentation and outcomes among female patients.
Topics include:
- Coronary artery disease (CAD)
- Acute coronary syndromes
- Pregnancy-associated CAD
- Microvascular dysfunction
- Ischemia with non-obstructive coronary arteries (INOCA)
- Diagnostic challenges in women
- Evidence-based treatment strategies
Participants learn to recognize atypical presentations and optimize cardiovascular outcomes.
Heart Failure & Cardiomyopathies
Dedicated sessions review contemporary management of heart failure and cardiomyopathy in women.
Topics include:
- Heart failure in women
- Heart failure with preserved ejection fraction (HFpEF)
- Hypertrophic cardiomyopathy
- Pregnancy-related cardiomyopathy
- Sex-specific treatment considerations
- Advanced heart failure therapies
Experts discuss individualized approaches for improving outcomes in female patients.
Arrhythmias & Electrophysiology
The symposium explores common rhythm disorders affecting women.
Topics include:
- Atrial fibrillation
- Catheter ablation
- Stroke prevention
- Anticoagulation strategies
- Sex differences in arrhythmia management
- Electrophysiology updates
Participants gain practical guidance on managing complex arrhythmias in women.
Valvular & Aortic Disease
Faculty review sex-specific considerations in structural heart disease.
Topics include:
- Mitral valve disease
- Tricuspid valve disease
- Aortic valve disorders
- Valve repair and replacement
- Aortic disease in women
- Structural heart interventions
- Outcomes following valve procedures
The course highlights evolving interventional approaches and treatment selection.
Cardiovascular-Kidney-Metabolic (CKM) Syndrome
A dedicated section focuses on the rapidly evolving field of cardiometabolic medicine.
Topics include:
- CKM syndrome
- Obesity management
- Diabetes and cardiovascular disease
- Chronic kidney disease
- Cardiometabolic risk reduction
- Integrated care models
Participants learn multidisciplinary approaches to managing complex cardiovascular risk profiles.
Advanced Pharmacologic Therapies
The symposium reviews modern cardiovascular therapeutics and guideline-directed medical therapy.
Topics include:
- PCSK9 inhibitors
- Inclisiran
- GLP-1 receptor agonists
- Semaglutide
- Finerenone
- Lipid-lowering therapies
- Antihypertensive strategies
- Hormone therapy considerations
Faculty discuss patient selection, safety, and clinical implementation.
Emerging Interventional & Device Therapies
The course also examines advanced procedural and device-based treatment options.
Topics include:
- Percutaneous valve repair
- Renal denervation
- Resistant hypertension management
- Baroreflex activation therapy
- Structural heart interventions
- Novel cardiovascular technologies
Clinicians gain insight into evolving treatment options for complex cardiovascular disease.
Core Topics Covered
- Cardiovascular Disease in Women
- Coronary Artery Disease
- Acute Coronary Syndromes in Pregnancy
- Atrial Fibrillation
- Cardiac Amyloidosis
- Hypertrophic Cardiomyopathy
- Heart Failure
- Hypertension
- Aortic Disease
- Valvular Heart Disease
- Chronic Venous Insufficiency
- ASCVD Prevention
- Lipid Management
- CKM Syndrome
- Women’s Preventive Cardiology
- Interventional Cardiology Advances
Target Audience
This course is ideal for:
- Cardiologists
- Internal Medicine Physicians
- Primary Care Physicians
- Women’s Health Specialists
- Nurse Practitioners
- Physician Assistants
- Pharmacists
- Cardiovascular Nurses
- Preventive Cardiology Providers
l title in this course
| Title | Runtime |
|---|---|
| Aortic Disease in Women: Diagnosis and Treatment | 22:47 |
| Atrial Fibrillation Ablation in Women | 22:39 |
| Sex Differences in Percutaneous Repair of Mitral and Tricuspid Valves | 24:04 |
| Finerenone and Semaglutide for the Treatment of Cardiovascular-Kidney-Metabolic (CKM) Syndrome | 21:23 |
| Acute Coronary Syndromes in Pregnancy | 20:48 |
| Therapeutic Options for Valvular Heart Disease in Young Women | 19:32 |
| Diagnosis and Treatment of Cardiac Amyloidosis in Women | 24:09 |
| Diagnosis and Management of Hypertrophic Cardiomyopathy in Women | 22:28 |
| Primary Prevention of ASCVD and Risk Assessment in Women | 16:02 |
| Management of Chronic Venous Insufficiency | 15:04 |
| Treatment of Hypertension: Role of Renal Denervation in Resistant Hypertension | 18:01 |
| New (and Traditional) Lipid Lowering Agents: Ezetimibe, PCSK9 Inhibitors, Inclisiran, Evanicumab, Bempedoic Acid | 21:20 |
| Baroreflex Activation Therapy (BAT) for Heart Failure with Reduced Ejection Fraction (HFrEF) | 12:40 |
| Updates in Medical Therapy for Heart Failure in Women | 19:50 |
| Cardiovascular Disease in Women: 2025 Update | 27:41 |









